ECHS1, an interacting protein of LASP1, induces sphingolipid-metabolism imbalance to promote colorectal cancer progression by regulating ceramide glycosylation
Rui Li(The First People's Hospital of Shunde), Liang Zhao(The First People's Hospital of Shunde)
Cited by 55
Related Papers
COPS5 and LASP1 synergistically interact to downregulate 14‐3‐3σ expression and promote colorectal cancer progression via activating PI3K/AKT pathway
|International Journal of Cancer|2017|70
Targeting vascular normalization: a promising strategy to improve immune–vascular crosstalk in cancer immunotherapy
|Frontiers in Immunology|2023|62
Pharmacological targeting PTK6 inhibits the JAK2/STAT3 sustained stemness and reverses chemoresistance of colorectal cancer
|Journal of Experimental & Clinical Cancer Research|2021|52
CCT8 recovers WTp53-suppressed cell cycle evolution and EMT to promote colorectal cancer progression
|Oncogenesis|2021|51
LASP1 promotes nasopharyngeal carcinoma progression through negatively regulation of the tumor suppressor PTEN
|Cell Death and Disease|2018|46